Platinum-coordinated graphitic carbon nitride nanosheet used for targeted inhibition of amyloid β-peptide aggregation

Nano Research

Volumn 9, Issue 8, 2016, Pages 2411-2423

  Li, Meng ^a,b   Guan, Yijia ^a,b   Chen, Zhaowei ^a,b   Gao, Nan ^a   Ren, Jinsong ^a   Dong, Kai ^a,b   Qu, Xiaogang ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

amyloid disease; amyloid peptide (A ) inhibitors; graphitic carbon nitride nanosheet; photooxygenation; platinum

Indexed keywords

BIOCOMPATIBILITY; CARBON NITRIDE; GLYCOPROTEINS; NANOSHEETS; NITRIDES; PEPTIDES; PHOTOCATALYTIC ACTIVITY; PLATINUM;

AMYLOID DISEASE; AMYLOID-BETA PEPTIDES; BLOOD-BRAIN BARRIER; GRAPHITIC CARBON NITRIDES; HIGH PHOTOCATALYTIC ACTIVITIES; PHOTOOXYGENATIONS; THERAPEUTIC STRATEGY; VISIBLE-LIGHT IRRADIATION;

PLATINUM COMPOUNDS;

EID: 84973137245     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-016-1127-5     Document Type: Article

References (66)

1. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science 2002, 297, 353–356.
2. Hamley, I. W. The amyloid beta peptide: A chemist’s perspective. Role in Alzheimer’s and fibrillization. Chem. Rev. 2012, 112, 5147–5192.
3. Jakob-Roetne, R.; Jacobsen, H. Alzheimer’s disease: From pathology to therapeutic approaches. Angew. Chem., Int. Ed. 2009, 48, 3030–3059.
4. Gaggelli, E.; Kozlowski, H.; Valensin, D.; Valensin, G. Copper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem. Rev. 2006, 106, 1995–2044.
5. Takeda, S.; Sato, N.; Uchio-Yamada, K.; Sawada, K.; Kunieda, T.; Takeuchi, D.; Kurinami, H.; Shinohara, M.; Rakugi, H.; Morishita, R. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. USA 2010, 107, 7036–7041.
6. Jin, M.; Shepardson, N.; Yang, T.; Chen, G.; Walsh, D.; Selkoe, D. J. Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. USA 2011, 108, 5819–5824.
7. De Felice, F. G.; Vieira, M. N. N.; Bomfim, T. R.; Decker, H.; Velasco, P. T.; Lambert, M. P.; Viola, K. L.; Zhao, W. Q.; Ferreira, S. T.; Klein, W. L. Protection of synapses against Alzheimer’s-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl. Acad. Sci. USA 2009, 106, 1971–1976.
8. Ono, K.; Condron, M. M.; Teplow, D. B. Structureneurotoxicity relationships of amyloid β-protein oligomers. Proc. Natl. Acad. Sci. USA 2009, 106, 14745–14750.
9. Takahashi, T.; Mihara, H. Peptide and protein mimetics inhibiting amyloid β-peptide aggregation. Acc. Chem. Res. 2008, 41, 1309–1318.
10. Frydman-Marom, A.; Rechter, M.; Shefler, I.; Bram, Y.; Shalev, D. E.; Gazit, E. Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies. Angew. Chem., Int. Ed. 2009, 48, 1981–1986.
11. Tjernberg, L. O.; Näslund, J.; Lindqvist, F.; Johansson, J.; Karlström, A. R.; Thyberg, J.; Terenius, L.; Nordstedt, C. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 1996, 271, 8545–8548.
12. Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15, 558–566.
13. Matlack, K. E. S.; Tardiff, D. F.; Narayan, P.; Hamamichi, S.; Caldwell, K. A.; Caldwell, G. A.; Lindquist, S. Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity. Proc. Natl. Acad. Sci. USA 2014, 111, 4013–4018.
14. Barnham, K. J.; Kenche, V. B.; Ciccotosto, G. D.; Smith, D. P.; Tew, D. J.; Liu, X.; Perez, K.; Cranston, G. A.; Johanssen, T. J.; Volitakis, I. et al. Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2008, 105, 6813–6818.
15. Hureau, C.; Faller, P. Platinoid complexes to target monomeric disordered peptides: A forthcoming solution against amyloid diseases? Dalton Trans. 2014, 43, 4233–4237.
16. Scott, L. E.; Orvig, C. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem. Rev. 2009, 109, 4885–4910.
17. Cassagnes, L.-E.; Hervé, V.; Nepveu, F.; Hureau, C.; Faller, P.; Collin, F. The catalytically active copper-amyloid-beta state: Coordination site responsible for reactive oxygen species production. Angew. Chem., Int. Ed. 2013, 52, 11110–11113.
18. Lim, S.; Paterson, B. M.; Fodero-Tavoletti, M. T.; O’Keefe, G. J.; Cappai, R.; Barnham, K. J.; Villemagne, V. L.; Donnelly, P. S. A copper radiopharmaceutical for diagnostic imaging of Alzheimer’s disease: A bis(thiosemicarbazonato)copper(II) complex that binds to amyloid-β plaques. Chem. Commun. 2010, 46, 5437–5439.
19. Ma, G. L.; Huang, F.; Pu, X. W.; Jia, L. Y.; Jiang, T.; Li, L. Z.; Liu, Y. Z. Identification of [PtCl2(phen)] binding modes in amyloid-β peptide and the mechanism of aggregation inhibition. Chem.—Eur. J. 2011, 17, 11657–11666.
20. Kenche, V. B.; Hung, L. W.; Perez, K.; Volitakes, I.; Ciccotosto, G.; Kwok, J.; Critch, N.; Sherratt, N.; Cortes, M.; Lal, V. et al. Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease. Angew. Chem., Int. Ed. 2013, 52, 3374–3378.
21. Man, B. Y.-W.; Chan, H.-M.; Leung, C.-H.; Chan, D. S.-H.; Bai, L.-P.; Jiang, Z.-H.; Li, H.-W.; Ma, D.-L. Group 9 metal-based inhibitors of β-amyloid (1–40) fibrillation as potential therapeutic agents for Alzheimer's disease. Chem. Sci. 2011, 2, 917–921.
22. Cabaleiro-Lago, C.; Quinlan-Pluck, F.; Lynch, I.; Lindman, S.; Minogue, A. M.; Thulin, E.; Walsh, D. M.; Dawson, K. A.; Linse, S. Inhibition of amyloid β protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 2008, 130, 15437–15443.
23. Yoo, S. I.; Yang, M.; Brender, J. R.; Subramanian, V.; Sun, K.; Joo, N. E.; Jeong, S.-H.; Ramamoorthy, A.; Kotov, N. A. Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: Functional similarities with proteins. Angew. Chem., Int. Ed. 2011, 50, 5110–5115.
24. Mahmoudi, M.; Akhavan, O.; Ghavami, M.; Rezaeeef, F.; Ghiasi, S. M. A. Graphene oxide strongly inhibits amyloid beta fibrillation. Nanoscale 2012, 4, 7322–7325.
25. 4@carbon metal-free electrocatalysts for highly efficient oxygen reduction. J. Am. Chem. Soc. 2011, 133, 20116–20119.
26. 4 fabricated by directly heating melamine. Langmuir 2009, 25, 10397–10401.
27. Komatsu, T. Attempted chemical synthesis of graphite-like carbon nitride. J. Mater. Chem. 2001, 11, 799–801.
28. Zheng, Y.; Lin, L. H.; Wang, B.; Wang, X. C. Graphitic carbon nitride polymers toward sustainable photoredox catalysis. Angew. Chem., Int. Ed. 2015, 54, 12868–12884.
29. Zhang, J. S.; Chen, Y.; Wang, X. C. Two-dimensional covalent carbon nitride nanosheets: Synthesis, functionalization, and applications. Energy Environ. Sci. 2015, 8, 3092–3108.
30. 2 ternary nanojunction with enhanced photoelectrochemical activity. Adv. Mater. 2013, 25, 6291–6297.
31. Fang, Y.; Lv, Y. Y.; Che, R. C.; Wu, H. Y.; Zhang, X. H.; Gu, D.; Zheng, G. F.; Zhao, D. Y. Two-dimensional mesoporous carbon nanosheets and their derived graphene nanosheets: Synthesis and efficient lithium ion storage. J. Am. Chem. Soc. 2013, 135, 1524–1530.
32. Tian, J. Q.; Liu, Q.; Ge, C. J.; Xing, Z. C.; Asiri, A. M.; Al-Youbi, A. O.; Sun, X. P. Ultrathin graphitic carbon nitride nanosheets: A low-cost, green, and highly efficient electrocatalyst toward the reduction of hydrogen peroxide and its glucose biosensing application. Nanoscale 2013, 5, 8921–8924.
33. Wang, Q. B.; Wang, W.; Lei, J. P.; Xu, N.; Gao, F. L.; Ju, H. X. Fluorescence quenching of carbon nitride nanosheet through its interaction with DNA for versatile fluorescence sensing. Anal. Chem. 2013, 85, 12182–12188.
34. 4 nanosheets for bioimaging. J. Am. Chem. Soc. 2013, 135, 18–21.
35. Lee, E. Z.; Jun, Y. S.; Hong, W. H.; Thomas, A.; Jin, M. M. Cubic mesoporous graphitic carbon(IV) nitride: An all-in-one chemosensor for selective optical sensing of metal ions. Angew. Chem., Int. Ed. 2010, 49, 9706–9710.
36. Tang, Y. R.; Song, H. J.; Su, Y. Y.; Lv, Y. Turn-on persistent luminescence probe based on graphitic carbon nitride for imaging detection of biothiols in biological fluids. Anal. Chem. 2013, 85, 11876–11884.
37. Li, M.; Zhao, C. Q.; Yang, X. J.; Ren, J. S.; Xu, C.; Qu, X. G. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe. Small 2013, 9, 52–55.
38. Klement, K.; Wieligmann, K.; Meinhardt, J.; Hortschansky, P.; Richter, W.; Fändrich, M. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer’s abeta(1–40) amyloid fibrils. J. Mol. Biol. 2007, 373, 1321–1333.
39. Wang, X. C.; Maeda, K.; Thomas, A.; Takanabe, K.; Xin, G.; Carlsson, J. M.; Domen, K.; Antonietti, M. A metal-free polymeric photocatalyst for hydrogen production from water under visible light. Nat. Mater. 2009, 8, 76–80.
40. 2 and visible light. J. Am. Chem. Soc. 2010, 132, 16299–16301.
41. 4 layered materials as novel efficient visible light driven photocatalysts. J. Mater. Chem. 2011, 21, 15171–15174.
42. Shalom, M.; Molinari, V.; Esposito, D.; Clavel, G.; Ressnig, D.; Giordano, C.; Antonietti, M. Sponge-like nickel and nickel nitride structures for catalytic applications. Adv. Mater. 2014, 26, 1272–1276.
43. Geng, J.; Li, M.; Ren, J. S.; Wang, E. B.; Qu, X. G. Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer’s disease. Angew. Chem., Int. Ed. 2011, 50, 4184–4188.
44. Yu, H. J.; Li, M.; Liu, G. P.; Geng, J.; Wang, J. Z.; Ren, J. S.; Zhao, C. Q.; Qu, X. G. Metallosupramolecular complex targeting an α/β discordant stretch of amyloid β peptide. Chem. Sci. 2012, 3, 3145–3153.
45. Schlamadinger, D. E.; Kats, D. I.; Kim, J. E. Quenching of tryptophan fluorescence in unfolded cytochrome c: A biophysics experiment for physical chemistry students. J. Chem. Educ. 2010, 87, 961–964.
46. Puchalski, M. M.; Morra, M. J.; von Wandruszka, R. Assessment of inner filter effect corrections in fluorimetry. Fresenius J. Anal. Chem. 1991, 340, 341–344.
47. Cheng, N. Y.; Tian, J. Q.; Liu, Q.; Ge, C. J.; Qusti, A. H.; Asiri, A. M.; Al-Youbi, A. O.; Sun, X. P. Au-nanoparticleloaded graphitic carbon nitride nanosheets: Green photocatalytic synthesis and application toward the degradation of organic pollutants. ACS Appl. Mater. Interfaces 2013, 5, 6815–6819.
48. Pei, W. B.; Wu, J. S.; Liu, J. L.; Ren, X. M.; Shen, L. J. Ion-pair complexes with strong near infrared absorbance: Syntheses, crystal structures and spectroscopic properties. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2010, 75, 191–197.
49. 2+. Anal. Chem. 2013, 85, 5595–5599.
50. Li, M.; Xu, C.; Wu, L.; Ren, J. S.; Wang, E. B.; Qu, X. G. Self-assembled peptide-polyoxometalate hybrid nanospheres: Two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer’s disease. Small 2013, 9, 3455–3461.
51. Mishra, R.; Bulic, B.; Sellin, D.; Jha, S.; Waldmann, H.; Winter, R. Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew. Chem., Int. Ed. 2008, 47, 4679–4682.
52. Li, M.; Yang, X. J.; Ren, J. S.; Qu, K. G.; Qu, X. G. Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease. Adv. Mater. 2012, 24, 1722–1728.
53. Petkova, A. T.; Leapman, R. D.; Guo, Z. H.; Yau, W.-M.; Mattson, M. P.; Tycko, R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 2005, 307, 262–265.
54. Balducci, C.; Beeg, M.; Stravalaci, M.; Bastone, A.; Sclip, A.; Biasini, E.; Tapella, L.; Colombo, L.; Manzoni, C.; Borsello, T. et al. Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA 2010, 107, 2295–2300.
55. Li, M.; Xu, C.; Ren, J. S.; Wang, E. B.; Qu, X. G. Photodegradation of β-sheet amyloid fibrils associated with Alzheimer’s disease by using polyoxometalates as photocatalysts. Chem. Commun. 2013, 49, 11394–11396.
56. Li, M.; Liu, Z.; Ren, J. S.; Qu, X. G. Inhibition of metalinduced amyloid aggregation using light-responsive magnetic nanoparticle prochelator conjugates. Chem. Sci. 2012, 3, 868–873.
57. Rastogi, R. P.; Singh, S. P.; Häder, D.-P.; Sinha, R. P. Detection of reactive oxygen species (ROS) by the oxidantsensing probe 2',7'-dichlorodihydrofluorescein diacetate in the cyanobacterium Anabaena variabilis PCC 7937. Biochem. Biophys. Res. Commun. 2010, 397, 603–607.
58. 2 on β-amyloid peptide (1–42). J. Photoch. Photobio. A: Chem. 2013, 254, 1–11.
59. Pramanik, D.; Ghosh, C.; Dey, S. G. Heme-Cu bound Aβ peptides: Spectroscopic characterization, reactivity, and relevance to Alzheimer's disease. J. Am. Chem. Soc. 2011, 133, 15545–15552.
60. Taniguchi, A.; Sasaki, D.; Shiohara, A.; Iwatsubo, T.; Tomita, T.; Sohma, Y.; Kanai, M. Attenuation of the aggregation and neurotoxicity of amyloid-β peptides by catalytic photooxygenation. Angew. Chem., Int. Ed. 2014, 53, 1382–1385.
61. D’Angelo, B.; Santucci, S.; Benedetti, E.; Di Loreto, S.; Phani, R.; Falone, S.; Amicarelli, F.; Cerù, M.; Cimini, A. Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr. Nanosci. 2009, 5, 167–176.
62. 2-responsive controlled drug release for potential Alzheimer's disease treatment. Chem. Sci. 2013, 4, 2536–2542.
63. Harris, M. E.; Hensley, K.; Butterfield, D. A.; Leedle, R. A.; Carney, J. M. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1–40) in cultured hippocampal neurons. Exp. Neurol. 1995, 131, 193–202.
64. Miranda, S.; Opazo, C.; Larrondo, L. F.; Muñoz, F. J.; Ruiz, F.; Leighton, F.; Inestrosa, N. C. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Prog. Neurobiol. 2000, 62, 633–648.
65. Liu, Y. L.; Ai, K. L.; Liu, J. H.; Yuan, Q. H.; He, Y. Y.; Lu, L. H. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew. Chem., Int. Ed. 2012, 51, 1437–1442.
66. 3+ up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging. Biomaterials 2013, 34, 1712–1721.